NCT00653341 Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s) Status COMPLETED Phase PHASE3
NCT00653302 Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine) Status COMPLETED Phase PHASE4
NCT00648453 Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial Function Status COMPLETED Phase PHASE4
NCT00646438 United States Coronary Artery Bypass Surgery (CABG) Diabetes Project (USCDP) Pilot Study Status UNKNOWN Phase NA
NCT00644124 Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma Status COMPLETED Phase PHASE1
NCT00642915 Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil) Status COMPLETED Phase PHASE4
NCT00638859 Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia Status COMPLETED Phase PHASE3
NCT00638534 Japanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis Media Status COMPLETED Phase PHASE3
NCT00638118 Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen Status COMPLETED Phase PHASE4
NCT00637884 A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms Status COMPLETED Phase PHASE4
NCT00637611 Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit Status COMPLETED Phase PHASE4
NCT00637585 Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine Status COMPLETED Phase PHASE4
NCT00637455 Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel Status COMPLETED Phase PHASE4
NCT00636870 Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine Status COMPLETED Phase PHASE4
NCT00634751 CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT00633425 Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride Status COMPLETED Phase PHASE4
NCT00632866 Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome Status COMPLETED Phase PHASE3